Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanlin Yin

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Cancer Management and Research|February 15, 2018
Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysisNing Pu, Jianang Li, Yaolin Xu, et al.
ACS Applied Materials & Interfaces|April 30, 2026
Imaging-Guided Macrophage-Targeted Nanotheranostics for Rheumatoid ArthritisXinyu Li, Shicheng Huo, Zhuocheng Lyu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 23, 2023
Tumor Microenvironment Responsive CD8<sup>+</sup> T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Based Synergistic Therapy for Pancreatic CancerQiangda Chen, Hanlin Yin, Junyi He, et al.
Annals of Translational Medicine|March 12, 2021
The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US population-based studyNing Pu, Joseph R Habib, Michael Bejjani, et al.
Annals of the Rheumatic Diseases|January 5, 2023
Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 studyLe Zhang, Jun Li, Hanlin Yin, et al.
Rheumatology (Oxford, England)|November 29, 2025
Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC)Chenhan Jia, Wanyi Lin, Chaoyu Gu, et al.
Arthritis Research & Therapy|January 23, 2024
Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expressionLichong Shen, Hanlin Yin, Li Sun, et al.
Cancer Biology & Medicine|April 30, 2026
Gut microbiota and pancreatic cancer: tumorigenesis, progression, and clinical applicationsChuxiong Cheng, Jingsong Wang, Jin Xie, et al.
Seminars in Arthritis and Rheumatism|August 17, 2025
Dual positivity for Anti-Ro52 and Anti-Ro60 antibodies is linked to greater organ involvement and disease progression in systemic sclerosisHanlin Yin, Wanyi Lin, Chenhan Jia, et al.
Arthritis Research & Therapy|August 18, 2023
Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expressionLichong Shen, Hanlin Yin, Li Sun, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Cancer Management and Research|February 15, 2018
Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysisNing Pu, Jianang Li, Yaolin Xu, et al.
ACS Applied Materials & Interfaces|April 30, 2026
Imaging-Guided Macrophage-Targeted Nanotheranostics for Rheumatoid ArthritisXinyu Li, Shicheng Huo, Zhuocheng Lyu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 23, 2023
Tumor Microenvironment Responsive CD8<sup>+</sup> T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Based Synergistic Therapy for Pancreatic CancerQiangda Chen, Hanlin Yin, Junyi He, et al.
Annals of Translational Medicine|March 12, 2021
The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US population-based studyNing Pu, Joseph R Habib, Michael Bejjani, et al.
Annals of the Rheumatic Diseases|January 5, 2023
Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 studyLe Zhang, Jun Li, Hanlin Yin, et al.
Rheumatology (Oxford, England)|November 29, 2025
Association of onset age with features of patients with systemic sclerosis in the Renji Scleroderma Longitudinal Cohort (Renji-SLOC)Chenhan Jia, Wanyi Lin, Chaoyu Gu, et al.
Arthritis Research & Therapy|January 23, 2024
Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expressionLichong Shen, Hanlin Yin, Li Sun, et al.
Cancer Biology & Medicine|April 30, 2026
Gut microbiota and pancreatic cancer: tumorigenesis, progression, and clinical applicationsChuxiong Cheng, Jingsong Wang, Jin Xie, et al.
Seminars in Arthritis and Rheumatism|August 17, 2025
Dual positivity for Anti-Ro52 and Anti-Ro60 antibodies is linked to greater organ involvement and disease progression in systemic sclerosisHanlin Yin, Wanyi Lin, Chenhan Jia, et al.
Arthritis Research & Therapy|August 18, 2023
Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expressionLichong Shen, Hanlin Yin, Li Sun, et al.
Pageof 9